Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

32,450

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

March 5, 2021

Study Completion Date

February 10, 2023

Conditions
COVID-19SARS-CoV-2
Interventions
BIOLOGICAL

AZD1222

AZD1222 is a recombinant replication-defective chimpanzee adenovirus expressing the SARS-CoV-2-5 surface glycoprotein.

BIOLOGICAL

Placebo

Commercially available 0.9% (n/V) saline for injection.

Trial Locations (84)

0

Research Site, Callao

10010

Research Site, New York

10016

Research Site, New York

10032

Research Site, New York

10467

Research Site, The Bronx

10595

Research Site, Valhalla

11220

Research Site, Brooklyn

11501

Research Site, Mineola

14621

Research Site, Rochester

14642

Research Site, Rochester

15036

Research Site, Lima

15232

Research Site, Pittsburgh

20889

Research Site, Bethesda

21201

Research Site, Baltimore

21205

Research Site, Baltimore

22060

Research Site, Fort Belvoir

23226

Research Site, Richmond

25309

Research Site, South Charleston

27710

Research Site, Durham

29303

Research Site, Spartanburg

29406

Research Site, North Charleston

29425

Research Site, Charleston

32803

Research Site, Orlando

33016

Research Site, Miami Lakes

33134

Research Site, Coral Gables

33462

Research Site, Lake Worth

37203

Research Site, Nashville

37920

Research Site, Knoxville

39503

Research Site, Gulfport

40509

Research Site, Lexington

43210

Research Site, Columbus

45229

Research Site, Cincinnati

46202

Research Site, Indianapolis

48073

Research Site, Royal Oak

48109

Research Site, Ann Arbor

50023

Research Site, Ankeny

55425

Research Site, Minneapolis

59701

Research Site, Butte

60612

Research Site, Chicago

66160

Research Site, Kansas City

66205

Research Site, Fairway

67207

Research Site, Wichita

67214

Research Site, Wichita

70601

Research Site, Lake Charles

71201

Research Site, Monroe

72212

Research Site, Little Rock

73099

Research Site, Yukon

75208

Research Site, Dallas

77030

Research Site, Houston

77381

Research Site, Spring

78234

Research Site, Fort Sam Houston

78236

Research Site, San Antonio

78504

Research Site, McAllen

78745

Research Site, Austin

80204

Research Site, Denver

83642

Research Site, Meridian

84088

Research Site, West Jordan

85018

Research Site, Phoenix

85258

Research Site, Scottsdale

87102

Research Site, Albuquerque

90033

Research Site, Los Angeles

90095

Research Site, Los Angeles

90502

Research Site, Torrance

92103

Research Site, San Diego

92134

Research Site, San Diego

92243

Research Site, El Centro

94102

Research Site, San Francisco

94158

Research Site, San Francisco

94705

Research Site, Berkeley

96814

Research Site, Honolulu

97239

Research Site, Portland

98109

Research Site, Seattle

2260000

Research Site, Quillota

7500539

Research Site, Santiago

8380453

Research Site, Santiago

06810

Research Site, Danbury

02111

Research Site, Boston

02215

Research Site, Boston

03801

Research Site, Portsmouth

08009

Research Site, Berlin

02886

Research Site, Warwick

05401

Research Site, Burlington

53792-5666

Research Site, Madison

LIMA 1

Research Site, Lima Cercado

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

AstraZeneca

INDUSTRY